Reduction in mydriatic drop size in premature infants.

In a prospective study of 26 premature infants, 5 microliters microdrops were compared with standard 26 microliters eye drops of cyclopentolate 0.5% and phenylephrine 2.5%. There was no statistical difference in pupil dilatation. The 5 microliters microdrops have potentially fewer adverse effects in premature infants.

[1]  A. Moore,et al.  Screening for retinopathy of prematurity , 1992, Eye.

[2]  R. Gray.  The influence of drop size on pupil dilatation , 1991, Eye.

[3]  R. Brown,et al.  Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption. , 1987, Archives of ophthalmology.

[4]  E. Palmer.  How safe are ocular drugs in pediatrics? , 1986, Ophthalmology.

[5]  M. Hermansen,et al.  Feeding intolerance following ophthalmologic examination. , 1985, American journal of diseases of children.

[6]  R. Brown,et al.  Creating smaller eyedrops by reducing eyedropper tip dimensions. , 1985, American journal of ophthalmology.

[7]  R. Rengstorff,et al.  Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. , 1982, American journal of optometry and physiological optics.

[8]  J W Shell,et al.  Pharmacokinetics of topically applied ophthalmic drugs. , 1982, Survey of ophthalmology.

[9]  S. Isenberg,et al.  Systemic effects of mydriatics in low weight infants. , 1981, Journal of pediatric ophthalmology and strabismus.

[10]  L. Cabal,et al.  Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants. , 1981, Pediatrics.

[11]  R. E. Kalina,et al.  Pupillary responses to mydriatic agents in premature infants. , 1973, American journal of ophthalmology.

[12]  C. Bauer,et al.  Systemic cyclopentolate (Cyclogyl) toxicity in the newborn infant. , 1973, The Journal of pediatrics.

[13]  W. Copeman.  DOCTORS AND DISEASE IN TUDOR TIMES , 1961 .

[14]  A. E. Stearn.  The Doctor in History , 1890, The Hospital.